Roble Belko & Company’s Eastman Chemical EMN Stock Holding History

Roble Belko & Company’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	–	–	448
2025 Q2	$0	Buy	+2	New	+$157	﹤0.01%	431

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Roble Belko & Company's EMN Position: Q3 2025 in Review

Roble Belko & Company sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 2 shares.

Roble Belko & Company first reported a position in EMN in Q2 2025 and held it in 1 quarter. The position peaked at $0 in Q2 2025. 662 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

Roble Belko & Company reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
Roble Belko & Company sold 2 Eastman Chemical shares in Q3 2025.
Roble Belko & Company first reported a position in Eastman Chemical in Q2 2025 and held it in 1 quarter.
Roble Belko & Company's Eastman Chemical position peaked at $0 in Q2 2025.
662 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Roble Belko & Company's 13F filing for Q3 2025, filed 24 Oct 2025.